Additionally, as the clinical landscape evolves, newer agents such as tirzepatide, a dual GIP/GLP-1 receptor agonist, may warrant dedicated evaluation to determine whether their unique mechanisms of action differentially influence eating behaviors and metabolic outcomes
Potential Benefits Works through amylin receptors rather than GLP-1, offering an alternative pathway for patients who may not respond optimally to GLP-1 medications alone
How does the PlexusDx Precision Peptide Genetic Test help with GLP-1 dosing
Among first-time prescriptions for which use could be established, ADMs accounted for 83.0% and AOMs accounted for 17.0%
Placebo effect, concurrent treatments, and selection bias skew results
It is required for the regulation of skin, nails, and hair